Okla. Stat. tit. 36, § 5403
Manufacturer Restrictions on Denials, Restrictions, and Interference of 340B Drugs - 340B Entity Contract Radius
Effective Nov 1, 2025Laws 2025, HB 2048, c. 332, § 4, eff. November 1, 2025.
- A. A manufacturer shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to a 340B entity, unless such receipt is prohibited by the United States Department of Health and Human Services.
- B. A manufacturer shall not interfere with a pharmacy contracted with a 340B entity.
- C. A 340B entity shall contract with any willing pharmacy upon mutually agreeable terms within a fifteen-mile radius of the 340B entity's location.
- D. Nothing in this section shall be construed to limit the number of pharmacies that a 340B entity shall be allowed to contract with.
Laws 2025, HB 2048, c. 332, § 4, eff. November 1, 2025.